Rheumatoid arthritis: open trials in Brazil

11 open trials have a site in Brazil. Registry data; only the trial team decides who can take part.

NCT07201558
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
Trial Treatment · Phase 1 · AstraZeneca
Porto Alegre · Salvador · São Paulo
Registry updated 2026-10-28
NCT07412704
A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
Trial Treatment · Phase 1/2 · Bristol-Myers Squibb
Aparecida de Goiânia · Porto Alegre · Valinhos
Registry updated 2026-10-23
NCT07137598
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
Trial Treatment · Phase 2 · Hoffmann-La Roche
L2IP - Instituto de Pesquisas Clínicas Ltda, Brasília · IPC MT Instituto de Pesquisas Clinicas do Mato Grosso, Cuiab · Centro de Estudos em Terapias Inovadoras ? CETI, Curitiba · Centro Mineiro de Pesquisa - CMiP, Juiz de Fora · Hospital So Lucas da PUCRS, Porto Alegre · Hospital das Clínicas FMRP-USP, Ribeirão Preto · CEPIC - Centro Paulista de Investigao Clnica e Servios Mdicos, So Paulo
Registry updated 2026-10-16
NCT07620392
An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
Trial Treatment · Phase 2 · Hoffmann-La Roche
Centro Mineiro de Pesquisa - CMiP, Juiz de Fora
Registry updated 2026-10-16
NCT07276581
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
Trial Treatment · Phase 2 · AstraZeneca
Juiz de Fora · Pelotas · Porto Alegre · Salvador · São Paulo
Registry updated 2026-10-09
NCT07774507
Twenty-four Hour Movement Behaviors and Atherosclerotic Risk
Research · São Paulo State University
Sao Paulo State University, Presidente Prudente
Registry updated 2026-08-20
NCT06991114
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Trial Treatment · Phase 2 · Artiva Biotherapeutics, Inc.
Artiva Investigational Site Brasília, Brasília · Artiva Investigational Site Cuiabá, Cuiabá · Artiva Investigational Site Porto Alegre, Porto Alegre · Artiva Investigational Site Rio Grande, Rio Grande · Artiva Investigational Site Sao Paulo, São Paulo
Registry updated 2026-07-31
NCT07087912
Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
Trial Treatment · Phase 4 · University of Sao Paulo General Hospital
Rheumatology Division, Faculdade de Medicina da USP, São Paulo · Hospital das Clinicas da Faculdade de Medicina da USP, São Paulo
Registry updated 2026-07-20
NCT07115745
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
Trial Treatment · Phase 1 · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Porto Alegre · Salvador · São Paulo
Registry updated 2026-07-14
NCT07371468
A Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)
Trial Treatment · Phase 1 · GlaxoSmithKline
Campinas · São Paulo
Registry updated 2026-06-23
NCT07162311
Effect of Home-Based Transcranial Direct Current Stimulation on Pain in Patients With Rheumatoid Arthritis With Low Inflammatory Activity
Trial Treatment · Federal University of Rio Grande do Sul
Hospital de Clinicas de Porto Alegre, Porto Alegre
Registry updated 2025-09-09

All Rheumatoid arthritis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error